Solarise Injection

the gynecologic cancer, head and neck cancer treatment

New-Drug-Development/2017-solarise-injectionThe Solarise drug optimization and pharmacodynamics of G&E's concerted effort now the implementation of dynamic analysis, and actually used in the treatment of wquamous cell head and neck cancer animal testing, in order to obtain more-in-depth Solarise animal efficacy and safety data, and more scalables studies with other quamous cell carcinoma in systemic organs, head and neck cancer, gynecologic cancer, such as human clinical trial studies continues to target its efficay and scientific based reports.